|Daily Range||$122.53 - $122.53|
|52-Week Range||$63.10 - $129.25|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||977|
|Current FY EPS||$5.09|
Gilead investors should look beyond the company’s antiviral portfolio and take a closer look at these hidden gems in its pipeline, which could shape the company’s long-term future.